Bridgeway Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,600
| Closed | -$1.87M | – | 1411 |
|
|
2023
Q2 | $1.87M | Hold |
2,600
| – | – | 0.04% | 571 |
|
|
2023
Q1 | $2.14M | Sell |
2,600
-2,700
| -51% | -$2.22M | 0.06% | 504 |
|
|
2022
Q4 | $3.82M | Sell |
5,300
-5,000
| -49% | -$3.61M | 0.1% | 343 |
|
|
2022
Q3 | $7.1M | Sell |
10,300
-5,800
| -36% | -$4M | 0.19% | 163 |
|
|
2022
Q2 | $9.52M | Buy |
16,100
+2,600
| +19% | +$1.54M | 0.22% | 138 |
|
|
2022
Q1 | $9.43M | Buy |
+13,500
| New | +$9.43M | 0.18% | 184 |
|
|
2021
Q1 | – | Sell |
-3,840
| Closed | -$1.86M | – | 1397 |
|
|
2020
Q4 | $1.86M | Sell |
3,840
-40
| -1% | -$19.3K | 0.04% | 550 |
|
|
2020
Q3 | $2.17M | Sell |
3,880
-37,020
| -91% | -$20.7M | 0.05% | 394 |
|
|
2020
Q2 | $25.5M | Buy |
+40,900
| New | +$25.5M | 0.52% | 72 |
|
|
2016
Q1 | – | Sell |
-11,200
| Closed | -$6.08M | – | 1475 |
|
|
2015
Q4 | $6.08M | Sell |
11,200
-5,400
| -33% | -$2.93M | 0.11% | 180 |
|
|
2015
Q3 | $7.72M | Hold |
16,600
| – | – | 0.16% | 157 |
|
|
2015
Q2 | $8.47M | Hold |
16,600
| – | – | 0.17% | 146 |
|
|
2015
Q1 | $7.5M | Hold |
16,600
| – | – | 0.15% | 148 |
|
|
2014
Q4 | $6.81M | Hold |
16,600
| – | – | 0.16% | 147 |
|
|
2014
Q3 | $5.99M | Hold |
16,600
| – | – | 0.15% | 162 |
|
|
2014
Q2 | $4.69M | Sell |
16,600
-3,000
| -15% | -$847K | 0.12% | 206 |
|
|
2014
Q1 | $5.89M | Hold |
19,600
| – | – | 0.17% | 126 |
|
|
2013
Q4 | $5.4M | Hold |
19,600
| – | – | 0.16% | 125 |
|
|
2013
Q3 | $6.13M | Hold |
19,600
| – | – | 0.21% | 81 |
|
|
2013
Q2 | $4.41M | Buy |
+19,600
| New | +$4.41M | 0.18% | 101 |
|